# Cibus, Inc. Class A Common Stock (CBUS)

> Cibus, Inc. Class A Common Stock (CBUS) trades at $1.13 (+3.67%) as of 7:55:11 PM EST on Nov 13, 2026, -12.40% over the past month. Market cap is $86.6M, with 61.8 days to cover in short interest.

Canonical: https://massive.com/quote/cbus
Data as of: 2026-11-14T00:55:11.566Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$1.13** +0.04 (+3.67%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$1.15** +0.02 (+1.77%)
As of 7:55:11 PM EST on Nov 13, 2026 · After hours

## Stock performance

How Cibus, Inc. Class A Common Stock (CBUS) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | +3.67% |
| 1W | -4.24% |
| 1M | -12.40% |
| YTD | -35.06% |
| 1Y | -2.59% |
| 52-wk range | $1.02 – $4.19 |

From daily closes through Nov 13, 2026.

## Key statistics

Today's trading snapshot for CBUS: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $1.02 – $1.14 |
| Open | $1.08 |
| Prev close | $1.09 |
| Volume | 148.9K |
| Market cap | $86.6M |
| Shares out | 76.43M |

## Valuation and profitability ratios

Valuation and profitability ratios for Cibus, Inc. Class A Common Stock: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 19.11 |
| P/B | -15.27 |
| P/FCF | — |
| ROE | 1703.6% |
| ROA | -32.0% |
| Debt/Equity | -0.10 |
| Div yield | 0.00% |

As of Nov 13, 2026

## Insider trading

[Cibus, Inc. Class A Common Stock (CBUS) insider trading](https://massive.com/quote/cbus/insider-trading.md): open-market Form 4 buys and sells by Cibus, Inc. Class A Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Cibus, Inc. Class A Common Stock has disclosed to the SEC on Form 8-K.

- Nov 12, 2026 · Business update
  “On November 12, 2026, Cibus, Inc. (the "Company") announced its financial results for the three months ended September 30, 2026, and provided a business update.”
- Jun 9, 2026 · Director departure
  “Concurrently with the appointment, Mr. Wichner resigned from the Board and from the Strategy Committee of the Board. To facilitate the Chief Executive Officer transition and related Board transition designed to enhance the independence of the Board, Dr. Beetham resigned from the Board also effective June 8, 2026.”
- Jun 5, 2026 · Annual meeting results
  “As a result, at the Annual Meeting, Mark Finn, Peter Beetham, Kimberly A. Box, Jean-Pierre Lehmann, August Moretti, Gerhard Prante, Rory Riggs, Thomas Urban, and Craig Wichner were elected as directors of the Company, each to serve a one-year term, the compensation of Company's named executive officers was approved (on an advisory basis), and the appointment of BDO USA, P.C. was ratified.”
- Apr 10, 2026 · Executive compensation change
  “Pursuant to the Company's Non-Employee Director Compensation Policy, the Board agreed to provide Mr. Urban with annual compensation comprising (i) a cash retainer equal to $60,000, payable semi-annually, and (ii) subject to Board approval and granting pursuant to the terms and provisions of the Cibus, Inc. 2017 Omnibus Incentive Plan, as amended, equity compensation with a grant date value equal to $90,000.”
- Mar 27, 2026 · Underwriting agreement
  “Pursuant to the Underwriting Agreement, the Underwriter will receive an underwriting discount of 7.0% of the gross proceeds received from the sale of the Shares in this Offering. In addition, the Company has agreed to reimburse the Underwriter for reasonable and documented out-of-pocket legal and other expenses incurred by them in connection with the Offering in an amount not to exceed $150,000.”

## Dividend history and stock splits

Cibus, Inc. Class A Common Stock's recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-10 · Apr 25, 2023
- 4-for-1 · May 6, 2008

## CBUS short interest

How heavily CBUS is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 61.8 |
| Short interest | 3.08M |
| Avg volume | 49.86K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## CBUS news

The latest news and headlines about Cibus, Inc. Class A Common Stock (CBUS).

- [Cibus (CBUS) Reports Q3 Loss, Lags Revenue Estimates](https://www.zacks.com/stock/news/3029083/cibus-cbus-reports-q3-loss-lags-revenue-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3029083) · Zacks Investment Research · Nov 12, 2026 · negative sentiment
- [Dole (DOLE) Q3 Earnings Miss Estimates](https://www.zacks.com/stock/news/3026078/dole-dole-q3-earnings-miss-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3026078) · Zacks Investment Research · Nov 9, 2026 · negative sentiment
- [Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation](https://www.globenewswire.com/news-release/2026/06/08/3308494/0/en/Cibus-Names-Agricultural-Biotechnology-Leader-Craig-Wichner-as-Chief-Executive-Officer-to-Accelerate-Growth-and-Value-Creation.html) · GlobeNewswire Inc. · Jun 8, 2026 · positive sentiment
- [Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production](https://www.globenewswire.com/news-release/2026/05/04/3286548/0/en/Cibus-Announces-Transfer-of-Gene-Edited-Herbicide-Tolerance-Traits-in-Interoc-Rice-Seeds-for-Testing-and-Production.html) · GlobeNewswire Inc. · May 4, 2026 · positive sentiment
- [Cibus Partnering with The John Innes Centre for UK Government’s Farming Innovation Programme Precision Breeding Initiative](https://www.globenewswire.com/news-release/2026/02/06/3233724/0/en/Cibus-Partnering-with-The-John-Innes-Centre-for-UK-Government-s-Farming-Innovation-Programme-Precision-Breeding-Initiative.html) · GlobeNewswire Inc. · Feb 6, 2026 · positive sentiment

## About Cibus, Inc. Class A Common Stock

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | AGRICULTURAL CHEMICALS |
| Employees | 118 |
| Listed | Jul 20, 2017 |

[Company website](https://www.cibus.com)

## FAQ

### What is the Cibus, Inc. Class A Common Stock (CBUS) stock price today?

Cibus, Inc. Class A Common Stock (CBUS) is trading at $1.13 (+3.67% on the day) as of 7:55:11 PM EST on Nov 13, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Cibus, Inc. Class A Common Stock?

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies.

### What is the short interest in CBUS?

As of Oct 30, 2026, CBUS has 3.08M shares short and 61.8 days to cover.

### What exchange is CBUS listed on?

Cibus, Inc. Class A Common Stock (CBUS) trades on Nasdaq in USD, in the AGRICULTURAL CHEMICALS industry.

## Live data

Prices here are 15-minute delayed. For real-time CBUS quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=CBUS`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Cibus, Inc. Class A Common Stock (CBUS) insider trading](https://massive.com/quote/cbus/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms